Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Fixed-duration BTKi-venetoclax combinations in CLL: optimizing patient-centered care. — SciRadar

Back to results

Expert review of anticancer therapy

Fixed-duration BTKi-venetoclax combinations in CLL: optimizing patient-centered care.

Stefano Molica, David Allsup

Published: 202510.1080/14737140.2025.2590674

No abstract available for this study.